Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14692
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJongkamonwiwat N.
dc.contributor.authorZine A.
dc.contributor.authorRivolta M.N.
dc.date.accessioned2021-04-05T03:36:31Z-
dc.date.available2021-04-05T03:36:31Z-
dc.date.issued2010
dc.identifier.issn13894501
dc.identifier.other2-s2.0-77954717756
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14692-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-77954717756&doi=10.2174%2f138945010791320836&partnerID=40&md5=4496b311412710c79ec3989935da5c6f
dc.description.abstractLosing one of our main sensory systems such as hearing can have devastating consequences in the way we interact with the world. The main problem lies in the fact that the critical sensory cells, the auditory neurons and hair cells located in the cochlea are only generated during development and, when damaged, cannot be replaced. The options currently available to treat this condition are very limited, and are mostly represented by prosthetic devices such as hearing aids and cochlear implants. There is a clear need for a therapeutic breakthrough that will help the millions of people affected, and the advances in stem cell technologies are offering a glimmer of hope for this affliction. Although still at a very early stage, a growing bulk of literature is being produced attempting to pave the path for a stem cell-based therapy for deafness. From the many variables to bear in mind when developing this approach, two appear to be of paramount importance. First, different cell types are potentially to be used, all of them having advantages and disadvantages. Second, in order to target such a small and secluded organ as the cochlea, difficult surgical techniques are to be used, some of which still need to be developed. The present article will aim to present the most recent advances of the field, focussing on these two critical issues. © 2010 Bentham Science Publishers Ltd.
dc.subjectciliary neurotrophic factor
dc.subjectdoxycycline
dc.subjectneurogenin 1
dc.subjectneurotrophic factor
dc.subjectarticle
dc.subjectcell type
dc.subjectcochlea duct
dc.subjectcochlea prosthesis
dc.subjectcochlear nerve
dc.subjectcochlear nucleus
dc.subjectCorti organ
dc.subjectear protection
dc.subjectembryonic stem cell
dc.subjecthearing impairment
dc.subjecthuman
dc.subjectinner ear
dc.subjectmesenchymal stem cell
dc.subjectmesenchymal stem cell transplantation
dc.subjectneural stem cell
dc.subjectnonhuman
dc.subjectpluripotent stem cell
dc.subjectprotein expression
dc.subjectspiral ganglion
dc.subjectstem cell transplantation
dc.subjectsurgical technique
dc.subjectAnimals
dc.subjectCochlea
dc.subjectCochlear Implantation
dc.subjectDeafness
dc.subjectHair Cells, Auditory
dc.subjectHumans
dc.subjectModels, Anatomic
dc.subjectNerve Growth Factors
dc.subjectRegeneration
dc.subjectSensory Receptor Cells
dc.subjectStem Cell Transplantation
dc.subjectStem Cells
dc.titleStem cell based therapy in the inner ear: Appropriate donor cell types and routes for transplantation
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationCurrent Drug Targets. Vol 11, No.7 (2010), p.888-897
dc.identifier.doi10.2174/138945010791320836
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.